First spherical artificial eye has 3D retina

Image

First spherical artificial eye has 3D retina

Scientists have developed the world's first 3D artificial eye with capabilities better than existing bionic eyes and in some cases, even exceed those of the human eyes, bringing vision to humanoid robots and new hope to patients with visual impairment.

The working principle of the artificial eye involves an electrochemical process which is adopted from a type of solar cell. In principle, each photo sensor on the artificial retina can serve as a nanoscale solar cell. With further modification, the EC-Eye can be a self-powered image sensor, so there is no need for external power source nor circuitry when used for ocular prosthesis, which will be much more user-friendly as compared with the current technology.

An international team led by scientists at the Hong Kong University of Science and Technology (HKUST) has recently developed the world's first 3D artificial eye with capabilities better than existing bionic eyes and in some cases, even exceed those of the human eyes, bringing vision to humanoid robots and new hope to patients with visual impairment. Scientists have spent decades trying to replicate the structure and clarity of a biological eye, but vision provided by existing prosthetic eyes-largely in the form of spectacles attached with external cables, are still in poor resolution with 2D flat image sensors. The Electrochemical Eye (EC-Eye) developed at HKUST, however, not only replicates the structure of a natural eye for the first time, but may actually offer sharper vision than a human eye in the future, with extra functions such as the ability to detect infrared radiation in darkness.

The key feature allowing such breakthroughs is a 3D artificial retina-made of an array of nanowire light sensors which mimic the photoreceptors in human retinas. Developed by Prof. FAN Zhiyong and Dr. GU Leilei from the Department of Electronic and Computer Engineering at HKUST, the team connected the nanowire light sensors to a bundle of liquid-metal wires serving as nerves behind the human-made hemispherical retina during the experiment, and successfully replicated the visual signal transmission to reflect what the eye sees onto the computer screen. In the future, those nanowire light sensors could be directly connected to the nerves of the visually impaired patients. Unlike in a human eye where bundles of optic nerve fibers (for signal transmission) need to route through the retina via a pore-from the front side of the retina to the backside (thus creating a blind spot in human vision) before reaching the brain; the light sensors that now scatters across the entire human-made retina could each feed signals through its own liquid-metal wire at the back, thereby eliminating the blind spot issue as they do not have to route through a single spot.

Apart from that, as nanowires have even higher density than photoreceptors in human retina, the artificial retina can thus receive more light signals and potentially attain a higher image resolution than human retina-if the back contacts to individual nanowires are made in the future. With different materials used to boost the sensors' sensitivity and spectral range, the artificial eye may also achieve other functions such as night vision.

The Ophthalmologist: Clinical and Therapeutic Journal is an open access, peer – reviewed, academic journal which has a wide range of fields which creates a platform for the authors to publish a relatively reliable source of information on recent technology, review articles, original articles etc. and provides free online access to the researchers worldwide. The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication. A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be uploaded directly through mail id: ophthalmologist@eclinicalsci.com

Media Contact
Sarah Rose
Journal Manager
The Ophthalmologist: Clinical and Therapeutic Journal
Email: ophthalmologist@eclinicalsci.com